Pregabalin in benzodiazepine withdrawal [4]

Pharmacopsychiatry

Volumn 40, Issue 6, 2007, Pages 292-293

  Biermann, T ^a   Bleich, S ^a   Kornhuber, J ^a   Hillemacher, T ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; BENZODIAZEPINE; DIAZEPAM; DOXEPIN; ESCITALOPRAM; PREGABALIN;

ADULT; AGITATION; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GASTROINTESTINAL IRRITATION; GENERALIZED ANXIETY DISORDER; HEADACHE; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; HYPESTHESIA; LETTER; MALE; MENTAL INSTABILITY; MYALGIA; PARESTHESIA; PRIORITY JOURNAL; SLEEP DISORDER; SOCIAL PHOBIA; TONGUE SWELLING; TREATMENT OUTCOME; TREMOR; WITHDRAWAL SYNDROME;

ADULT; ALPRAZOLAM; ANTICONVULSANTS; ANXIETY DISORDERS; GAMMA-AMINOBUTYRIC ACID; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PHOBIC DISORDERS; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 36849046919     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-992146     Document Type: Letter

References (6)

1. Bateson A. Further potential of the GABA receptor in the treatment of insomnia. Sleep Medicine 2007; 7: 3-9
2. Montgomery SA. Pregabalin for the treatment of generalized anxiety disorder. Expert Opin Pharmacother 2006; 7: 2139-2154
3. Rupprecht R, Eser D, Zwanzger P, Möller HJ. GABA-A receptors as targets for novel anxiolytic drugs. World J Biol Psychiatry 2006; 7: 231-237
4. Taylor CP, Angelotti T, Fauman E. Pharmacology and mechanism of action of pregabalin: the calcium channel alpha2-delta (alpha2-delta) subunit as a target for antiepileptic drug discovery. Epilepsy Res 2007; 73: 137-150
5. Victorri-Vigneau C, Guerlais M, Jolliet P. Abuse, dependency and withdrawal with gabapentin: a first case report. Pharmacopsychiatry 2007; 40: 43-44
6. Zuilino DF, Khazaal Y, Hattenschwiler J, Borgeat F, Besson J. Anticonvulsant drugs in the treatment of substance withdrawal. Drugs Today (Barc) 2004; 40: 603-619